Barzegar, Mansoureh <br/><br/>
SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling.  [electronic resource] 

 -  British journal of cancer  Oct 2017 
 - 1154-1163 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/bjc.2017.298  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Blotting, Western<br/>Carcinoma, Squamous Cell--metabolism<br/>Cell Proliferation--drug effects<br/>Cyclin A--drug effects<br/>Cyclin D1--drug effects<br/>Cyclin-Dependent Kinase 2--drug effects<br/>Cyclin-Dependent Kinase 4--drug effects<br/>Cyclin-Dependent Kinase Inhibitor p21--drug effects<br/>Cyclin-Dependent Kinase Inhibitor p27--drug effects<br/>Down-Regulation<br/>ErbB Receptors--antagonists & inhibitors<br/>G1 Phase Cell Cycle Checkpoints--drug effects<br/>Head and Neck Neoplasms--metabolism<br/>Humans<br/>Immunohistochemistry<br/>In Situ Nick-End Labeling<br/>In Vitro Techniques<br/>Mice<br/>Mice, Nude<br/>Molecular Docking Simulation<br/>Purines--pharmacology<br/>Signal Transduction<br/>Squamous Cell Carcinoma of Head and Neck<br/>Up-Regulation<br/>Xenograft Model Antitumor Assays<br/>cdc25 Phosphatases--drug effects